Tuesday, December 08, 2020 12:01:07 AM
https://www.nurixtx.com/research-development/strategic-partnerships/
Wellington and Baker Brothers are among Institutional Ownership and Shareholders:
https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA
Recent NRIX News
- Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases • GlobeNewswire Inc. • 01/13/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/11/2025 02:33:13 AM
- Nurix Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 10:28:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2025 09:20:18 PM
- Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia • GlobeNewswire Inc. • 12/19/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 11:54:30 AM
- Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting • GlobeNewswire Inc. • 12/09/2024 11:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 11:00:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 09:36:23 PM
- Nurix Therapeutics Announces Webcast To Review New Data from Its Phase 1 Clinical Trial of BTK Degrader NX-5948 Presented at the 66th American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 12/02/2024 12:00:00 PM
- Nurix Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/25/2024 12:00:00 PM
- Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia • GlobeNewswire Inc. • 11/20/2024 09:00:00 PM
- Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 • GlobeNewswire Inc. • 11/17/2024 03:30:00 PM
- Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 11/05/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 10:48:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/04/2024 09:29:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 09:57:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 09:57:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:50:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:41:44 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/31/2024 08:36:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:12:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2024 08:01:58 PM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • ZEFI • Jan 15, 2025 7:33 AM